EVOLUS INC
EOLS·30052C107·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G
EOLS (EVOLUS INC) is held by 79 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($17.6M), VANGUARD CAPITAL MANAGEMENT LLC ($10.2M), MILLENNIUM MANAGEMENT LLC ($6M). Net institutional sentiment: Mixed.
79
Holders
(8 Elite)
$86M
Total Value
47% (88)
Consensus
41 buying - 47 selling
13F: Insider & Congress:
Who's Trading
InsiderMDMOATAZEDI DAVIDSell $65KMar 20, 2026
InsiderARAvelar RuiSell $15KMar 20, 2026
InsiderMDMOATAZEDI DAVIDSell $571KMar 17, 2026
InsiderARAvelar RuiSell $147KMar 17, 2026
ActivistTATANG CAPITAL MANAGEMENT, LLC1.9%Feb 17, 2026
ActivistTPTimothy P. Lynch9.9%Feb 17, 2026
ActivistCACaligan Partners LP0.0%Feb 17, 2026
InsiderARAvelar RuiSell $16KDec 22, 2025
InsiderMDMOATAZEDI DAVIDSell $75KDec 22, 2025
Showing 1-20 of 95
1 / 5
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer